PRN: Global Tissue Diagnostics Market 2016-2020 - Insurance Coverage and Reimbursement Issues are a Major Market Challenge

Global Tissue Diagnostics Market 2016-2020 - Insurance Coverage and Reimbursement Issues are a Major Market Challenge [03-March-2016] DUBLIN, March 3, 2016 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nn7x7w/global_tissue) has announced the addition of the "Global Tissue Diagnostics Market 2016-2020" report to their offering.

Persone Laura Wood, Enzo Biochem
Luoghi Oxford, Dublino, Stati Uniti d'America
Organizzazioni Hours, Protea Biosciences Group, Olympus Diagnostics Systems Group, Agilent Technologies, Global Tissue Diagnostics Market
Argomenti economia, commercio, impresa, internet, finanza

03/mar/2016 18.10.10 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Tissue Diagnostics Market 2016-2020 - Insurance Coverage and Reimbursement Issues are a Major Market Challenge

 
[03-March-2016]
 

DUBLIN, March 3, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/nn7x7w/global_tissue) has announced the addition of the "Global Tissue Diagnostics Market 2016-2020" report to their offering.

The global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020. 

Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Ready-to-use reagents help minimize calculation, dilution, and pipetting errors, reduce the duration of the diagnostic procedure, and prevent contamination of samples. These factors have resulted in the demand for ready-to-use reagents among clinical laboratories and hospitals.

According to the report, hospital-based pathology laboratories widely use tissue diagnostics for disease diagnosis, while pharmaceutical companies use them for drug discovery. Advances in technology are leading academia and research institutes, reference pathology laboratories, and medical research centers worldwide to use tissue diagnostics for various medical purposes. The implementation of tissue diagnostics by these new consumers can become a turning point for the market in the coming years.

Further, the report states that the insurance coverage and reimbursement policies for tissue diagnostics continue to concern policy makers and are leading individuals to opt for conventional therapies.

To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:

- Advanced staining - Preanalytical and routine staining - Digital pathology

Key vendors:

- Abbott Diagnostics - Agilent Technologies (a parent company of Dako) - Danaher (a parent company of Leica Biosystems) - Roche Diagnostics

Other prominent vendors:

- 20/20 GeneSystems - Abcam - AdnaGen - Advanced Cell Diagnostics - Affymetrix - Agendia - AutoGenomics - AVIVA BioSciences - Biocare Medical - Biocartis - Cancer Genetics - ELITechGroup - Enzo Biochem - Epic Sciences - Fluidigm - HORIBA Medical - Janssen Diagnostics - Olympus Diagnostics Systems Group - Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US) - Oxford Gene Technology - PANAGENE - Protea Biosciences Group - Sakura Finetek

For more information visit http://www.researchandmarkets.com/research/nn7x7w/global_tissue

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl